Blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia that has relapsed. Read More
Yet transmission-risk misunderstandings persist, finds large NIH-supported study. Read More
Researchers used data from 46,709 women in the Sister Study. Read More
NIH-funded research shows no difference in efficacy or adverse effects of commonly used treatments. Read More
Study Leaders Publish Results from NIH-DRC-WHO Clinical Trial of Four Experimental Therapies. Read More
Scientists have determined that La Crosse virus, which can cause inflammation of the brain in children, affects brain cells differently depending on their developmental stage. Read More
NIH is playing a pivotal role in supporting the innovative science underpinning the effort to reduce the incidence of HIV domestically by 75% in 5 years, and by 90% by 2030. Read More
Children of first-time mothers, those in home-based childcare log most screen time. Read More
Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies. Read More
Although EEE has existed for centuries, 2019 has been a particularly deadly year for the disease in the United States. Read More
